Sort   by:  
 Page size 
GenomicsExpression data of H838 KRAS mutation isogenic cell lines
Expression data of H838 KRAS mutation isogenic cell lines
PRJNA488261 | ENA
TranscriptomicsExpression data of H838 KRAS mutation isogenic cell lines
To explore the distinct mechanism of KRAS G12V and G12D mutation. We used microarray to explore the distinct differences in gene expression profiles of H838 KRAS mutation isogenic cell lines
ORGANISM(S): Homo sapiens 
2020-05-21 | GSE119146 | GEO
GenomicsTranscriptome sequencing of human lung cancer cell line NCI-H838 treated with LINC00472 overexpression
Transcriptome sequencing of human lung cancer cell line NCI-H838 treated with LINC00472 overexpression
PRJNA689592 | ENA
Transcriptomics3' sequencing following arginine methylation inhibition in a panel of cancer cell lines
Numerous RNA-binding proteins involved in alternative polyadenylation are arginine methylation substrates. Therefore we aimed to study how alternative polyadenylation is impacted by preventing arginine methylation, and assess how conserved this phenotype is across a panel of cancer lines with differ...
ORGANISM(S): Homo sapiens 
2026-10-19 | E-MTAB-14932 | biostudies-arrayexpress
TranscriptomicsRNA-seq analysis of SMARCA4-deficient NCI-H838 xenograft tumors treated with PRT3789, docetaxel, nab-paclitaxel, or combination regimens
The goal of this study was to examine transcriptional responses to the SMARCA2-selective degrader PRT3789, standard chemotherapies, and their combinations in SMARCA4-deficient NCI-H838 xenograft tumors. Six treatment groups were evaluated: (1) vehicle control, (2) PRT3789, (3) docetaxel, (4) nab-pac...
ORGANISM(S): Homo sapiens 
2025-09-12 | GSE307427 | GEO
GenomicsRNA-seq analysis of SMARCA4-deficient NCI-H838 xenograft tumors treated with PRT3789, docetaxel, nab-paclitaxel, or combination regimens
RNA-seq analysis of SMARCA4-deficient NCI-H838 xenograft tumors treated with PRT3789, docetaxel, nab-paclitaxel, or combination regimens
PRJNA1321661 | ENA
GenomicsRespones to treatment of H209 and H838 cell lines to treatment with the non-covalent inhibitor of TRXR1, DKFZ-608
Respones to treatment of H209 and H838 cell lines to treatment with the non-covalent inhibitor of TRXR1, DKFZ-608
PRJNA508383 | ENA
GenomicsMindbomb1 is a Novel Negative Regulator of BMP Signaling (H838: MIB1 iKO)
Mindbomb1 is a Novel Negative Regulator of BMP Signaling (H838: MIB1 iKO)
PRJNA1150941 | ENA
GenomicsMindbomb1 is a Novel Negative Regulator of BMP Signaling (H838: MIB1 iKO, +BMP4, -/+ BMP inhibitor)
Mindbomb1 is a Novel Negative Regulator of BMP Signaling (H838: MIB1 iKO, +BMP4, -/+ BMP inhibitor)
PRJNA1150942 | ENA
TranscriptomicsEndothelial stromal cells enhance lung-tumor cell migration through TNFα and SDF-1α secretion
Recent studies have noted the tumor-stroma interaction as an integral part of tumor growth and spread as well as novel avenues for effective treatment. However, the details by which tumor and stroma cells communicate remain poorly understood. Here we show that the migration speed of the non-small-ce...
ORGANISM(S): Homo sapiens 
2020-08-20 | GSE42076 | GEO
Sort   by:  
 Page size